|
* Breaking Mexican laws regarding purchasing of drugs may lead to your arrest in the Mexico. |
* Breaking U. |
| D. |
01 by the log-rank test) but not with enalapril (4%, P=0. |
| It isn't worth the risks you are taking with your health and your freedom. |
WEDNESDAY, July 1 (HealthDay News) -- Older people who signed up for Medicare's prescription drug coverage, called Part D, spent more on drugs after enrolling than they had before but less on other types of medical care, researchers have found. |
| If you have questions about current laws regarding importation of drugs, contact U.after four cycles of platinum-based first-line chemotherapy
[Lilly Press Release]
7/7 Lantus: 5-Yr Prospective Trial; Retinopathy Equals That Of NPH
5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH
5-year study of Lantus(R) (insulin glargine [rDNA] injection) versus NPH insulin on progression of retinopathy in patients with type 2 diabetes, published on-line in Diabetologia (DOI 10. |
The study suggested that drug overuse might have been partly responsible in this group and, to a lesser extent, in the other two groups. This kind of off-label use
[Investor's Business Daily]
7/6 Resistant TB: Class Of Parkinson's Drug (Nitrocatechols) May Be Effective
Parkinson's drugs show promise in resistant TB
tolcapone or Tasmar made by Valeant Pharmaceuticals, and entacapone or Comtan made by Novartis AG have the potential to treat multiple-drug-resistant and extensively drug-resistant strains of TB
molecular structure also allows them to block a compound that TB bugs need to build their protective cell wall
. |
| People in the first three groups all switched to Part D as of 2006. market
[Reuters]
7/6 NEJM Article Challenges Conventional Diabetic Wisdom:
ACE Inhibitors, ARBS Fail To Ameliorate Nephropathy In Type 1's
ACE, ARB Slow Retinopathy but Not Nephropathy in Type 1 Diabetes
unexpected and unexplained" increase in microalbuminuria
285 patients with type 1 diabetes but normal albumin excretion and blood pressure levels. |
This seemed to correlate with an improvement in greater ability to afford medications, the study found. |
S., but would be used to blunt the effect of an expected shortage in Gaucher's disease drug made by Genzyme Corp
[BizJournal]
See Also: Protalix Asked to Widen Gaucher-Drug Supply
[Wall Street Journal; $$$]
See Also: Protalix's New Carrot Derived Drug Likely to Win FDA Approval
[CNBC]
7/7 Generic Maker Caraco Lays Off 1/2 Workforce; Quality Control Lapse
Caraco Pharmaceuticals lays off 350
jobs indefinitely after federal authorities shut down distribution at all the company's Michigan plants last month citing faulty manufacturing practices
[Detroit News]
See Also: Similar Report From NASDAQ; adds U.
paxil tramadol |
S. |
31 on the Web site drugstore.
tramadol feelings online tramadol hydrocodone addiction |
WEDNESDAY, July 1 (HealthDay News) -- Older people who signed up for Medicare's prescription drug coverage, called Part D, spent more on drugs after enrolling than they had before but less on other types of medical care, researchers have found.16 ; as a frame of reference, generic maker Taro has a market cap of $311mln (similar P/E) and Mylan is worth $3. |
| "Some people also argued that if medication compliance improved, maybe that would potentially save the other non-drug medical-care spending.
* Although this is not a border issue, you should know that obtaining controlled substances from a foreign source via the internet or mail order is illegal unless you are an approved, registered importer with DEA. |
7/7 Aricept Patent Battle Gordian Knot Head Scratcher
Apotex Challenges Eisai's Patents on Alzheimer's Drug Aricept
A bottle with 180, 10- milligram tablets of Aricept costs $1,155. |
| S.S. |
* Do not assume that Mexican pharmacy employees have any medical training. Food and Drug Administration last month seized more than 30 of its generic drugs for QC violations such as oversized pills. |
| gov]
7/6 Zevalin: Complete Response Letter
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for Zevalin
Does Not Involve New Clinical Studies or New Data Analyses
FDA requested the Company to submit data files from the FIT study to support and verify a subset of the data that are currently under review
[Spectrum Pharmaceuticals Press Release]
7/6 Provenge Approval Possible Mid-1010 Launch;
Efficacy = Extra 4 Months Vs. |
Still thinking of buying drugs in Mexico.
My advice: think twice. |